BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1277192)

  • 1. The sensitivities of human and murine hemopoietic cells exposed to cytotoxic drugs in an in vivo culture system.
    Gordon MY; Blackett N
    Cancer Res; 1976 Aug; 36(8):2822-6. PubMed ID: 1277192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of hematologic toxicity of antineoplastic agents with their effects on bone marrow stem cells: interspecies studies using an in vivo assay.
    Marsh JC
    Exp Hematol; 1985; 13 Suppl 16():16-22. PubMed ID: 3987835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the sensitivities of human, canine, and murine hematopoietic precursor cells to adriamycin and N-trifluoroacetyladriamycin-14-valerate.
    Marsh JC
    Cancer Res; 1979 Feb; 39(2 Pt 1):360-4. PubMed ID: 761207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of bone marrow hematopoietic colony-forming cells from mice, dogs, and humans to carminomycin, marcellomycin, aclacinomycin A, and N,N-dibenzyldaunorubicin and its relationship to clinical toxicity.
    Marsh JC; Brown BJ; Nierenburg MM
    Cancer Res; 1983 Jun; 43(6):2962-6. PubMed ID: 6573955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of cytotoxic agents on hematopoietic progenitors.
    Botnick LE; Hannon EC; Vigneulle R; Hellman S
    Cancer Res; 1981 Jun; 41(6):2338-42. PubMed ID: 7237432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of tumor necrosis factor on murine hematopoiesis during cycle-specific cytotoxic chemotherapy.
    Slørdal L; Warren DJ; Moore MA
    Cancer Res; 1990 Jul; 50(14):4216-20. PubMed ID: 2364379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the agar diffusion chamber for the exposure of human tumor cells to drugs.
    Selby PJ; Steel GG
    Cancer Res; 1982 Nov; 42(11):4758-62. PubMed ID: 7127312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
    Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
    Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of methotrexate, two nonclassic folic acid antagonists, and cytarabine on hematopoietic precursor cells.
    Marsh JC
    Cancer Treat Rep; 1982 Mar; 66(3):499-504. PubMed ID: 6460555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
    Ajani JA; Blaauw AA; Spitzer G; Baker FL; Tomasovic B; Umbach G; Thielvoldt D; Zander AR; Dicke KA
    Exp Hematol; 1985; 13 Suppl 16():95-100. PubMed ID: 2580731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The toxic action of antineoplastic chemotherapeutic agents evaluated by study of hemopoietic stem cells].
    Pannacciulli I; Ghio R; Bianchi G; Bogliolo G; Saviane A; Massa G
    Minerva Med; 1978 Dec; 69(61):4257-65. PubMed ID: 366466
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose-survival curves of cis-platinum, melphalan, and velban in human granulocyte/macrophage progenitor cells.
    Umbach GE; Singletary SE; Tomasovic B; Spitzer G; Hug V; Drewinko B
    Int J Cell Cloning; 1984 Nov; 2(6):335-40. PubMed ID: 6542929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for measuring suppression of hematopoiesis.
    Chervenick PA
    Exp Hematol; 1985; 13 Suppl 16():8-15. PubMed ID: 3987838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term consequences of chemotherapeutic agents on hematopoiesis: development of altered radiation tolerance.
    Kovacs CJ; Evans MJ; Hooker JL; Johnke RM
    NCI Monogr; 1988; (6):45-9. PubMed ID: 3352788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro effects of cyclophosphamide derivatives on murine bone marrow-derived stromal and hemopoietic progenitor cell classes.
    de Jong JP; Nikkels PG; Brockbank KG; Ploemacher RE; Voerman JS
    Cancer Res; 1985 Sep; 45(9):4001-5. PubMed ID: 3896474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cis-diamminedichloroplatinum (NSC 119875) on murine and human hemopoietic precursor cells.
    Ogawa M; Gale GR; Keirn SS
    Cancer Res; 1975 Jun; 35(6):1398-401. PubMed ID: 1131815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of cytotoxic drugs for residual bone marrow damage.
    Trainor KJ; Morley AA
    J Natl Cancer Inst; 1976 Dec; 57(6):1237-9. PubMed ID: 1003558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effect of cytotoxic agents on agar colony forming cells, spleen colony forming cells, and the erythrocytic repopulating ability of mouse bone marrow.
    Millard RE; Blackett NM; Okell SF
    J Cell Physiol; 1973 Oct; 82(2):309-17. PubMed ID: 4753424
    [No Abstract]   [Full Text] [Related]  

  • 19. Humoral stimulation of hemopoietic progenitors from human fetal liver.
    Niskanen E; Champlin R; Oki A; Golde DW; Gale RP; Cline MJ
    Stem Cells (1981); 1982; 2(4):246-52. PubMed ID: 6132450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemopoietic stem cells and antitumoral drugs. 1. Variations of in vitro and in vivo colony forming cells following single dose administration of cyclophosphamide, vinblastine and azathioprine (author's transl)].
    Pannacciulli I; Ghio R; Bogliolo G; Massa G; Saviane A; Bianchi G
    Haematologica; 1976 Dec; 61(4):432-8. PubMed ID: 828607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.